Privia Health
PRVA
122 hedge funds and large institutions have $1.62B invested in Privia Health in 2021 Q4 according to their latest regulatory filings, with 43 funds opening new positions, 41 increasing their positions, 26 reducing their positions, and 11 closing their positions.
291% more first-time investments, than exits
New positions opened: 43 | Existing positions closed: 11
66% more call options, than puts
Call options by funds: $1.04M | Put options by funds: $626K
58% more repeat investments, than reductions
Existing positions increased: 41 | Existing positions reduced: 26
36% more funds holding
Funds holding: 90 → 122 (+32)
26% more capital invested
Capital invested by funds: $1.28B → $1.62B (+$334M)
7.25% more ownership
Funds ownership: 51.45% → 58.7% (+7.2%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
+$61.2M |
| 2 |
RP
Riverbridge Partners
Minneapolis,
Minnesota
|
+$44.6M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
+$40.9M |
| 4 |
Bank of New York Mellon
New York
|
+$30.4M |
| 5 |
SIG
Senator Investment Group
New York
|
+$17.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
-$62.5M |
| 2 |
Capital International Investors
Los Angeles,
California
|
-$27.7M |
| 3 |
BlackRock
New York
|
-$13.3M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$11.6M |
| 5 |
AM
Ares Management
Los Angeles,
California
|
-$8.08M |
PRVA Hedge Fund Activity: Q4 2021 in Review
122 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in Privia Health (PRVA) for Q4 2021, worth a combined $1.62B — up 26% from $1.28B a quarter earlier.
Buyers outnumbered sellers: 43 funds opened new PRVA positions and 11 closed out — a net gain of 32 holders — while 41 added to existing stakes and 26 trimmed.
The largest buyer was ArrowMark Colorado Holdings, adding an estimated $61.2M. The largest seller was Goldman Sachs, cutting an estimated $62.5M.
- 122 institutional investors held Privia Health (PRVA) as of Q4 2021, up from 90 in Q3 2021.
- Funds reported $1.62B of Privia Health stock for Q4 2021, up 26% quarter-over-quarter.
- 43 funds opened new Privia Health positions in Q4 2021 and 11 closed out, a net change of +32 holders.
- The largest Privia Health buyer in Q4 2021 was ArrowMark Colorado Holdings, an estimated $61.2M added.
- The largest Privia Health seller in Q4 2021 was Goldman Sachs, an estimated $62.5M sold.
Based on aggregated 13F filings for Q4 2021.